Gynecologic Oncology Group

5 articles with Gynecologic Oncology Group

• 

  Breakthrough Cervical Cancer Treatment Wins Accelerated FDA Approval

  9/21/2021

  It earned the FDA's green light after its Phase II innovaTV 204 clinical trial delivered stellar results in terms of tumor response and durability of the response.

• Gynecologic Oncology Group Commences Enrollment In Stage 2 Of GOG-0265 Clinical Trial

  3/11/2015

• Gynecologic Oncology Group Phase 2 Study Of Advaxis, Inc.'s Lm-LLO Immunotherapy, ADXS-HPV, For The Treatment Of Persistent Or Recurrent Cervical Cancer Achieves Safety And Efficacy Criteria

  1/28/2015

• Gynecologic Oncology Group and Advaxis, Inc. Release: Dosing Begins for GOG US Cervical Cancer Study Evaluating ADXS-HPV

  1/11/2012

• Advaxis, Inc. to Host Dinner Reception For Members of the Gynecologic Oncology Group

  1/23/2008